Over the 90-day window ending December 12, 2025, UroGen Pharma's three dominant insider ownership positions are held by Chief Medical Officer Mark Schoenberg (139.03K shares), Chief Financial Officer Chris Degnan (2.28K shares), Director James A. Jr. Robinson (2.00K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ran Nussbaum | 1,481,927 | 25 Oct, 2022 | |
| Arie Belldegrun | 408,693 | 16 Sep, 2022 | |
| Elizabeth A. Barrett | Chief Executive Officer | 326,691 | 02 Feb, 2023 |
| Mark Schoenberg | Chief Medical Officer | 139,025 | 20 Nov, 2025 |
| Fred E Cohen | 69,339 | 28 Jul, 2023 | |
| Jason Drew Smith | General Counsel | 43,305 | 09 Sep, 2025 |
| Dong Kim | Chief Financial Officer | 37,753 | 12 Sep, 2024 |
| Molly Henderson | Chief Financial Officer | 5,248 | 02 Feb, 2022 |
| Chris Degnan | Chief Financial Officer | 2,280 | 09 Oct, 2025 |
| Daniel George Wildman | 2,000 | 01 Dec, 2025 | |
| James A. Jr. Robinson | 2,000 | 01 Dec, 2025 | |
| Leana Wen | 2,000 | 01 Dec, 2025 | |
| Cynthia M Butitta | 2,000 | 01 Dec, 2025 | |
| Stuart Holden | 2,000 | 01 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Nov, 2025 | Stuart Holden | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Cynthia M Butitta | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Daniel George Wildman | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | James A. Jr. Robinson | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Leana Wen | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 19 Nov, 2025 | Mark Schoenberg | Ordinary Shares | D | 10,000 | $25.00 | 139,025 | D | S |
| 08 Oct, 2025 | Chris Degnan | Ordinary Shares | A | 4,483 | - | 4,483 | D | M |
| 08 Oct, 2025 | Chris Degnan | Ordinary Shares | D | 2,203 | $16.85 | 2,280 | D | S |
| 07 Sep, 2025 | Mark Schoenberg | Ordinary Shares | A | 1,667 | - | 149,896 | D | M |
| 07 Sep, 2025 | Jason Drew Smith | Ordinary Shares | A | 3,333 | - | 44,825 | D | M |
| 08 Sep, 2025 | Jason Drew Smith | Ordinary Shares | D | 1,520 | $19.11 | 43,305 | D | S |
| 08 Sep, 2025 | Mark Schoenberg | Ordinary Shares | D | 871 | $19.11 | 149,025 | D | S |
| 11 Aug, 2025 | Mark Schoenberg | Ordinary Shares | D | 10,000 | $17.69 | 148,229 | D | S |
| 28 Jul, 2025 | Jason Drew Smith | - | - | 49,014 | D | |||
| 28 Jul, 2025 | Mark Schoenberg | Ordinary Shares | A | 10,000 | - | 163,378 | D | M |
| 28 Jul, 2025 | Jason Drew Smith | Ordinary Shares | A | 16,500 | - | 49,014 | D | M |
| 28 Jul, 2025 | Mark Schoenberg | Ordinary Shares | D | 5,149 | $19.14 | 158,229 | D | S |
| 28 Jul, 2025 | Jason Drew Smith | - | - | 41,492 | D | |||
| 28 Jul, 2025 | Jason Drew Smith | Ordinary Shares | D | 7,522 | $19.14 | 41,492 | D | S |
| 08 Jun, 2025 | Mark Schoenberg | Ordinary Shares | A | 10,000 | - | 158,540 | D | M |